Antigen Express, the Worcester-based subsidiary of Toronto’s Generex Biotechnology Corporation (OTCMKTS:GNBT), said a Phase II clinical trial of a cancer vaccine corroborates earlier tests. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04 in last session, and closed at $0.0375, while the day range of GNBT stock is $0.04 – $0.04. The stock showed a negative weekly performance of -6.25%.
Aegis Capital maintains Valeant Pharmaceuticals Intl Inc (NYSE:VRX) at Buy with a 12-month price target of $160 following the announcement Monday that it will acquire PreCision Dermatology. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock opened at $145.40, in last session and closed at $146.34, by gaining 0.88%. The 52 week range of VRX is $64.55 – $150.17. Company’s market capitalization is $48.75billion.
Delcath Systems, Inc. (NASDAQ:DCTH) announced that it will host a conference call and webcast on Wednesday, March 12, 2014 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year of 2013 ended December 31, 2013, and provide an update on recent corporate progress. Delcath Systems, Inc. (NASDAQ:DCTH) stock decreased -1.59% and finished the last session at $0.310. The EPS of the stock remained -0.40. Company’s market capitalization is $39.16million.
Alkermes Plc (NASDAQ:ALKS) CMO Elliot Ehrich sold 7,718 shares of Alkermes Plc (NASDAQ:ALKS) stock on the open market in a transaction that occurred. Alkermes Plc (NASDAQ:ALKS) stock opened the session at $53.44, and closed the session at $52.71. The 52 week range of the ALKS stock remained $19.77 – $54.25 and the day range was $52.49 – $53.93.